O GoConqr está de visual novo! Conte para nós o que você achou.

Mapa mental

Congestive Heart Failure Management

Katie Anderson Nursing Inglês

Congestive Heart Failure Management

Conteúdo do mapa

Congestive Heart Failure Management

  1. Medication Therapy

    • Wolters Kluwer Clinical Drug Information. (2018). Lexicomp online. Retrieved February 16, 2018, from https://online-lexi-com.eztest.ocls.ca/lco/action/home?siteid=1
      • Angiotensin Converting Enzyme (ACE) Inhibitors
        • Produce vasodilation (reduction in BP) by inhibiting formation of angiotensin II
        • Monitor For: hypotension, cough, hyperkalemia, deteriorating renal function, neutropenia (captopril)
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Calcium Channel Blockers (CCB)
        • Produce vasodialtion by Inhibiting uptake of the calcium ion in smooth muscle (cardiac & peripheral)
        • Monitor For: Increase in chest pain, hypotension, peripheral edema, may reduce coronary perfusion
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Nitrates
        • By relaxing the smooth muscle, vasodilation occurs promoting oxygen supply to the tissues
        • Monitor For: hypotension, dizziness, abdominal pain, weakness, dyspnea
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Angiotensin Receptor Neprilysin Inhibitor (ARNI)
        • Inhibits Neprilysin resulting in the increase of BNP and bradykinin allowing for vasodilation
        • Monitor For: Orthostatic hypotension, dizziness, falls, cough, hyperkalemia, hypercreatinemia
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Mineralocorticoid Receptor Antagonists (MRA)
        • Competitive binding at the aldosterone dependent sodium potassium exchange site in the kidney
        • Monitor For: Gynacomastia, ED, hepatotoxicity, increased BUN, lethargy, hyponatremia
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance, potassium sparing properties
      • Cardiac Glycosides
        • Increase intracellular sodium and availability of calcium ions, results in improved contractility increasing cardiac output
          • Dougherty, C. M. (1985). The nursing diagnosis of decreased cardiac output. The Nursing clinics of North America, 20(4), 787-799.
            • Symptom Management: Arrhythmia, increased tissue perfusion, decrease in fatigue, increased activity tolerance, decreased anxiety
        • Monitor For: HR <60bpm, bradycardia, atrial tachycardia, 1st/2nd/3rd degree heart block, dizziness, nausea, vomiting, mental disturbances, headache
        • Lab Values: Ensure therapeutic levels are within range to ensure optimal treatment impact
      • Beta Blockers
        • Block the effects of epinephrine, resulting in a decrease in contractility and heart rate decreasing blood pressure
        • Monitor for: bradycardia, heart failure, chest pain, confusion, ED, constipation, lethargy
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Angiotensin II Receptor Blockers (ARBs)
        • Monitor For: hypotension, hyperkalemia, hyperglycemia, hypercreatinemia, anxiety, parathesia
        • Blocks the action of Angiotensin II, resulting in vasodialtion and hypotension
        • Symptom Management: BP, tissue perfusion, cardiac workload, increased activity tolerance
      • Diuretics
        • Block the reabsorption of sodium, increasing urine output, assisting in decreasing blood pressure
        • Monitor For: Hypokalemia, hypotension, hyperglycemia, headache, dizziness, restlessness
        • Symptom Management: Hypertension, hyperkalemia, dyspnea, ascites, fatigue, improved appetite, decreased peripheral edema (adventitious sounds), cough, increased activity tolerance
      • Opiods (Palliative)
        • Inhibit neurotransmitter release, resulting in ananalgesic effect
        • Monitor for : Increased drowsiness, respiratory depression, headache, constipation, nausea, vomiting
        • Symptom Management: Decreased WOB and pain
  2. Nutrition

    • Lewis, S., Dirksen, S., Heitkemper, M., Bucher, L., & Camera, I. (3rd ed.). (2014). Medical- Surgical Nursing in Canada. Toronto, Canada: Elsevier.
      • Diet
        • Low Sodium
          • <1.5-2.0g
          • Reduces hypertension
          • Reduces fluid retention
          • Avoid processed foods
        • Low Cholesterol
          • Decreases hypertension
          • Meats low in saturated fats
          • Decrease risk of MI and plaque formation
          • Fresh fruits and vegetables
        • Avoid alcohol
        • Restrict fluid intake
          • 1.5-2.0 L
          • Reduce fluid retention
            • Signs & Symptoms
              • SOB
              • Edema
              • Crackles
              • Restlessness
              • Anxiety
              • Change in LOC
              • Weight gain
              • Ascites
            • Interventions
              • Monitor urine output
                • Indicates fluid retention
                • Assess need for indwelling catheter
              • Congestive Heart Failure (CHF) Nursing Care Plan & Management. (2017, July). Retrieved March 03, 2018, from https://www.rnpedia.com/nursing-notes/medical -surgical-nursing-notes/congestive-heart-failure-chf/
                • Auscultate lung sounds Q2h
                • Assess sputum production Q2h
                • monitor VS Q4h
                • Assess for JVD
                • Monitor edema
                  • Peripheral
                  • Ascites
                  • Reposition Q2h; Assist into high-fowlers
                    • Decrease stress on heart & lungs
                • Q24h weight
                  • 1kg = 2L of fluid
                  • Gain of 2+ lbs maintained over 48+ hrs indicates retention
                • Monitor Lab Results
                  • K+
                    • 3.5-5.0 mmol/L
                    • High: Acute or chronic renal failure, Addison's disease, dehydration, diabetic ketosis, excessive dietary/IV intake, massive tissue destruction, metabolic acidosis
                    • Low: Burns, Cushing's syndrome, deficient dietary or IV intake, diarrhea (severe), diuretic therapy, GI fistula, insulin administration, pyloric obstruction, starvation, vomiting
                    • Element in resting membrane potential of neurons, maintenance of cardiac rhythms, conduction of nerve impulses and smooth muscle contraction
                  • Na+
                    • Low: Addison's disease, decreased sodium intake in dietary or IV intake, diabetic ketoacidosis, diuretic therapy, excessive loss from GI tract, excessive perspiration, water intoxication
                    • High: Corticosteroid therapy, dehydration, impaired renal function, increased sodium intake in diet/IV, primary aldosteronism
                    • 135-145 mmol/L
                    • Impacts the intra and extracellular fluid balance, nerve impulses, and the acid-base balance
                  • Creatinine
                    • High: Anemia, leukemia, muscular atrophy, salmonellosis
                    • 7.1-17.7 mmol/day
                    • Low: Renal disease
                    • Byproduct of muscle breakdown (creatinine phosphate) excreted through the kidneys
                  • Brain Natriuretic Peptide
                    • High: Congestive heart failure, MI, hypertension, cor pulmonale
                    • A peptide which causes natriuresis, reducing fluid retention
                    • <100 ng/L
                  • Troponin
                    • Contractile proteins released following an MI, sampling often done in conjunction with CK-MB and ECGs.
                    • <0.5mcg/L is negative for myocardial injury, >2.3mcg/L indicates myocardial injury
                    • High: Cardiac muscle damage, (MI, myocarditis or pericarditis), chronic renal failure, multiorgan failure, severe heart failure
                  • BUN
                    • High: Burns, dehydration, GI bleeds, increase in protein catabolism (fever, stress), renal disease, shock, urinary tract infection
                    • Low: Fluid overload, malnutrition, severe liver damage, SIADH
                    • Determines the kidneys' ability to properly excrete waste
                    • 3.6-7.1 mmol/L
                  • ABG
                    • Indicate balance or imbalance in the oxygen, carbon dioxide, and pH levels within the blood
                    • Metabolic alkalosis; ineffective bicarbonate excretion through the kidneys with elevated pH
                    • Respiratory Alkalosis: ineffective alveolar ventilation leading to a decreased partial pressure ( PaCO2)
                    • Urso, C., Brucculeri, S., & Caimi, G. (2015). Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Failure Reviews, 20(4), 493–503. http://doi.org/10.1007/s10741-015-9482-y
                      • Most commonly metabolic or respiratory alkalosis impacts patients in heart failure, however they can experience any form or combination of blood gas imbalances
                    • pH (7.35-7.45) PCO2 (34-45) PO2 (83-108) HCO3 (21-28)
                • Monitor LOC
        • High Calorie
          • Facilitate metabolic needs
  3. Education

    • American Heart Association. (2018). (n.d). Classes of Heart Failure. Retrieved March 03, 2018, from http.//www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeart Failure/Classes-of-Heart-Failure_UCM_306328_Article.jsp#.WpBeEyMZPR0
      • NYHA Scale
        • NYHA Class 1: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).
        • NYHA Class 2: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).
        • NYHA Class 3: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.
        • NYHA Class 4: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.
    • Cardiac Care Network. (2014). Strategy for community management of heart failure in Ontario. Retrieved February 16, 2018, from http://www.ccn.on.ca/ccn_public/uploadfiles/files/ Strategy_for_Community_Mgmt_in_HF_in_ON.pdf
      • Patient Supports
        • Linkages to outpatient services through the hospital and in the community to ensure care integration and connection across the system
          • Support for collaborative care with patient and family to recognize changes in condition and promote independent self-care
        • Interdisciplinary teams to promote holistic care
        • In Home Suppport
          • CHF patients often need home care support
            • CCAC facilitates care services
            • Nursing
              • Heart failure specialist
              • Health teaching
                • Disease process
                • Medication management/ compliance
              • information about community resources
            • PSW
              • Assist with ADLs
            • Social work
              • Family and patient supports
            • Physio/OT
              • Assist with exercise techniques
              • Teach energy conservation techniques
            • Palliative care
              • Comfort measures
              • Family meetings
            • Pharmacy
              • Medication changes
              • Dosettes
            • Speech language pathology
              • Swallowing tests
            • Dietary
              • High calorie
              • low sodium
              • Fluid restriction
        • LTC
          • Care management
            • Medication
            • Dietary
            • Rehab
            • Patient care needs/ADLs
        • Cardiac Rehabilitation
          • nutrition counselling
          • Smoking cessation
          • Stress management
          • Exercise classes
  4. Exercise & Mobility

    • Respiratory
      • Hammond, M. D., Bauer, K. A., Sharp, J. T., & Rocha, R. D. (1990). Respiratory muscle strength in congestive heart failure. Chest, 98(5), 1091-1094.
        • Reduced strength and endurance of muscle tissue resulting in respiratory failure
          • Adventitious Sounds
          • Pleural edema
          • Promote deep breathing and coughing
            • Expell phlegm
        • Respiratory muscle weakness
          • Increased WOB
          • Fatigue
        • Decreased perfusion to respiratory tissues
          • Increased oxygen demands
    • Energy Management
      • Lewis, S., Dirksen, S., Heitkemper, M., Bucher, L., & Camera, I. (3rd ed.). (2014). Medical- Surgical Nursing in Canada. Toronto, Canada: Elsevier.
        • Encourage alternating periods of rest and activity
          • Teach self-care techniques to minimize energy consumption
            • Reduce energy consumption and O2 demands
            • Pace yourself and take breaks
          • Promote relaxing activities to provide distraction
            • Decreases HR and BP, reducing stress on the heart
        • Encourage clients to have meals up in the chair
          • Prevention of DVT
          • Pressure Ulcer Prevention
        • Monitor Response to Activity
          • Vital signs
          • Helps to determine activity tolerance

Imagens e arquivos do mapa

  • Congestive Heart Failure Management
  • Congestive Heart Failure Management
  • Congestive Heart Failure Management
  • Congestive Heart Failure Management
  • Congestive Heart Failure Management

Informações

Descrição
Nursing Mapa Mental sobre Congestive Heart Failure Management, criado por Katie Anderson em 04-03-2018.
Criado por
Katie Anderson
Visualizações
13
Avaliação

Fale Conosco

Sobre o que é sua mensagem?

O que você acha do novo visual?

Você gostou?